2023-2027年全球寡核甘酸合成市場

寡核甘酸合成市場預計在 2022-2027 年期間增長 28.7069 億美元，預測期內復合年增長率為 13.47%。

本報告包括對寡核甘酸合成市場的總體分析、市場規模/預測、趨勢、市場促進因素/促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。

我們提供有關當前市場情況、最新趨勢和促進因素以及整體市場環境的最新分析。 該市場的促進因素包括製藥和生物技術領域研究活動的增加、寡核甘酸作為治療和診斷工具的使用的增加以及寡核甘酸合成技術創新的不斷發展。

這項研究指出，對新寡核甘酸藥物研發的日益關注是推動未來幾年寡核甘酸合成市場增長的主要原因之一。 此外，研究經費的增加和對低成本、高通量寡核甘酸合成的需求不斷增長預計將帶來巨大的市場需求。

目錄

第 1 章執行摘要

• 市場概覽

第 2 章市場情況

• 市場生態系統

第 3 章市場規模

• 市場定義
• 細分市場分析
• 2022 年市場規模
• 2022-2027 年市場展望

第 4 章市場規模結果

• 2017-2021年全球寡核甘酸合成市場
• 2017-2021 年按應用劃分的細分市場分析
• 2017-2021 年最終用戶細分分析
• 2017-2021 年區域細分分析
• 2017-2021 年國家/地區細分分析

第 5 章五力分析

• 五力總結
• 買方的議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第 6 章市場細分：按應用

• 細分市場
• 比較：按用途
• PCR 引物：2022-2027 年市場規模和預測
• 螢光原位雜交：2022-2027 年市場規模和預測
• PCR 檢測試劑盒：2022-2027 年市場規模和預測
• DNA 微陣列：2022-2027 年市場規模和預測
• 其他：2022-2027 年市場規模和預測
• 市場機會：按應用分類

第 7 章市場細分：按最終用戶劃分

• 細分市場
• 比較：按最終用戶劃分
• 製藥和生物技術公司：2022-2027 年市場規模和預測
• 研究和學術機構：2022-2027 年市場規模和預測
• 診斷實驗室：2022-2027 年市場規模和預測
• 醫院：2022-2027 年市場規模和預測
• 市場機會：按最終用戶劃分

第 8 章客戶情況

• 客戶情況概覽

第 9 章區域情況

• 區域細分
• 按地區比較
• 北美：2022-2027 年市場規模和預測
• 歐洲：2022-2027 年市場規模和預測
• 亞洲：2022-2027 年市場規模和預測
• 世界其他地區：2022-2027 年市場規模和預測
• 美國：2022-2027 年市場規模和預測
• 中國：2022-2027 年市場規模及預測
• 德國：2022-2027 年市場規模和預測
• 加拿大：2022-2027 年市場規模和預測
• 日本：2022-2027 年市場規模和預測
• 市場機會：按地區情況劃分

第 10 章促進因素、挑戰和趨勢

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場趨勢

第 11 章供應商情況

• 摘要
• 供應商情況
• 混亂的情況
• 行業風險

第 12 章供應商分析

• 目標供應商
• 供應商市場定位
• Agilent Technologies Inc.
• Alnylam Pharmaceuticals Inc.
• Biogen Inc.
• Biotage AB
• Danaher Corp.
• Eurofins Scientific SE
• Ionis Pharmaceuticals Inc.
• Kaneka Corp.
• LGC Science Group Holdings Ltd.
• Maravai LifeSciences Holdings Inc.
• Merck KGaA
• Mettler Toledo International Inc.
• Sarepta Therapeutics Inc
• Synbio Technologies
• Thermo Fisher Scientific Inc.

第 13 章附錄

The oligonucleotide synthesis market is forecasted to grow by USD 2,870.69 mn during 2022-2027, accelerating at a CAGR of 13.47% during the forecast period. The report on the oligonucleotide synthesis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing research activities in pharmaceutical and biotechnology sectors, increasing use of oligonucleotides as therapeutic and diagnostic tools, and emergence of technological innovations in oligonucleotide synthesis.

Technavio's oligonucleotide synthesis market is segmented as below:

By Application

• PCR primers
• Flurorescence in situ hybridization
• PCR assays and panels
• DNA microarrays
• Others

By End-user

• Pharmaceutical and biotechnology companies
• Research and academic institutes
• Diagnostic laboratories
• Hospitals

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing focus on R & D of new oligonucleotide therapeutics as one of the prime reasons driving the oligonucleotide synthesis market growth during the next few years. Also, increasing research funding and rise in demand for low-cost and high-throughput oligonucleotide synthesis will lead to sizable demand in the market.

The report on the oligonucleotide synthesis market covers the following areas:

• Oligonucleotide synthesis market sizing
• Oligonucleotide synthesis market forecast
• Oligonucleotide synthesis market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oligonucleotide synthesis market vendors that include Agilent Technologies Inc., Ajinomoto Co. Inc., Alnylam Pharmaceuticals Inc., Bio Synthesis Inc, Biocon Ltd., Biotage AB, Danaher Corp., Eurofins Scientific SE, General Electric Co., Ionis Pharmaceuticals Inc., Kaneka Corp., LGC Science Group Holdings Ltd., Maravai LifeSciences Holdings Inc., Merck KGaA, Mettler Toledo International Inc., QIAGEN NV, Sarepta Therapeutics Inc, Synbio Technologies, Thermo Fisher Scientific Inc., and Biogen Inc.. Also, the oligonucleotide synthesis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global oligonucleotide synthesis market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global oligonucleotide synthesis market 2017 - 2021 ($ billion)
• 4.2 Applications Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Applications Segment 2017 - 2021 ($ billion)
• 4.3 End-user Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 PCR primers - Market size and forecast 2022-2027
• Exhibit 34: Chart on PCR primers - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on PCR primers - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on PCR primers - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on PCR primers - Year-over-year growth 2022-2027 (%)
• 6.4 Fluorescence in situ hybridization - Market size and forecast 2022-2027
• Exhibit 38: Chart on Fluorescence in situ hybridization - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on Fluorescence in situ hybridization - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on Fluorescence in situ hybridization - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Fluorescence in situ hybridization - Year-over-year growth 2022-2027 (%)
• 6.5 PCR assays and panels - Market size and forecast 2022-2027
• Exhibit 42: Chart on PCR assays and panels - Market size and forecast 2022-2027 ($ billion)
• Exhibit 43: Data Table on PCR assays and panels - Market size and forecast 2022-2027 ($ billion)
• Exhibit 44: Chart on PCR assays and panels - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on PCR assays and panels - Year-over-year growth 2022-2027 (%)
• 6.6 DNA microarrays - Market size and forecast 2022-2027
• Exhibit 46: Chart on DNA microarrays - Market size and forecast 2022-2027 ($ billion)
• Exhibit 47: Data Table on DNA microarrays - Market size and forecast 2022-2027 ($ billion)
• Exhibit 48: Chart on DNA microarrays - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on DNA microarrays - Year-over-year growth 2022-2027 (%)
• 6.7 Others - Market size and forecast 2022-2027
• Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 6.8 Market opportunity by Application
• Exhibit 54: Market opportunity by Application ($ billion)
• Exhibit 55: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 56: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 57: Data Table on End-user - Market share 2022-2027 (%)
• 7.2 Comparison by End-user
• Exhibit 58: Chart on Comparison by End-user
• Exhibit 59: Data Table on Comparison by End-user
• 7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
• Exhibit 60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ billion)
• Exhibit 62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
• 7.4 Research and academic institutes - Market size and forecast 2022-2027
• Exhibit 64: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
• Exhibit 65: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
• Exhibit 66: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)
• 7.5 Diagnostic laboratories - Market size and forecast 2022-2027
• Exhibit 68: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
• Exhibit 69: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
• Exhibit 70: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
• 7.6 Hospitals - Market size and forecast 2022-2027
• Exhibit 72: Chart on Hospitals - Market size and forecast 2022-2027 ($ billion)
• Exhibit 73: Data Table on Hospitals - Market size and forecast 2022-2027 ($ billion)
• Exhibit 74: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 75: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
• 7.7 Market opportunity by End-user
• Exhibit 76: Market opportunity by End-user ($ billion)
• Exhibit 77: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 81: Chart on Geographic comparison
• Exhibit 82: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 China - Market size and forecast 2022-2027
• Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 Canada - Market size and forecast 2022-2027
• Exhibit 111: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 112: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 113: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 114: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.11 Japan - Market size and forecast 2022-2027
• Exhibit 115: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibit 116: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibit 117: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 118: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 119: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 121: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 123: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 124: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 125: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 126: Matrix on vendor position and classification
• 12.3 Agilent Technologies Inc.
• Exhibit 127: Agilent Technologies Inc. - Overview
• Exhibit 128: Agilent Technologies Inc. - Business segments
• Exhibit 129: Agilent Technologies Inc. - Key offerings
• Exhibit 130: Agilent Technologies Inc. - Segment focus
• 12.4 Alnylam Pharmaceuticals Inc.
• Exhibit 131: Alnylam Pharmaceuticals Inc. - Overview
• Exhibit 132: Alnylam Pharmaceuticals Inc. - Product / Service
• Exhibit 133: Alnylam Pharmaceuticals Inc. - Key news
• Exhibit 134: Alnylam Pharmaceuticals Inc. - Key offerings
• 12.5 Biogen Inc.
• Exhibit 135: Biogen Inc. - Overview
• Exhibit 136: Biogen Inc. - Product / Service
• Exhibit 137: Biogen Inc. - Key offerings
• 12.6 Biotage AB
• Exhibit 138: Biotage AB - Overview
• Exhibit 139: Biotage AB - Product / Service
• Exhibit 140: Biotage AB - Key news
• Exhibit 141: Biotage AB - Key offerings
• 12.7 Danaher Corp.
• Exhibit 142: Danaher Corp. - Overview
• Exhibit 143: Danaher Corp. - Business segments
• Exhibit 144: Danaher Corp. - Key news
• Exhibit 145: Danaher Corp. - Key offerings
• Exhibit 146: Danaher Corp. - Segment focus
• 12.8 Eurofins Scientific SE
• Exhibit 147: Eurofins Scientific SE - Overview
• Exhibit 148: Eurofins Scientific SE - Business segments
• Exhibit 149: Eurofins Scientific SE - Key news
• Exhibit 150: Eurofins Scientific SE - Key offerings
• Exhibit 151: Eurofins Scientific SE - Segment focus
• 12.9 Ionis Pharmaceuticals Inc.
• Exhibit 152: Ionis Pharmaceuticals Inc. - Overview
• Exhibit 153: Ionis Pharmaceuticals Inc. - Business segments
• Exhibit 154: Ionis Pharmaceuticals Inc. - Key news
• Exhibit 155: Ionis Pharmaceuticals Inc. - Key offerings
• Exhibit 156: Ionis Pharmaceuticals Inc. - Segment focus
• 12.10 Kaneka Corp.
• Exhibit 157: Kaneka Corp. - Overview
• Exhibit 158: Kaneka Corp. - Business segments
• Exhibit 159: Kaneka Corp. - Key offerings
• Exhibit 160: Kaneka Corp. - Segment focus
• 12.11 LGC Science Group Holdings Ltd.
• Exhibit 161: LGC Science Group Holdings Ltd. - Overview
• Exhibit 162: LGC Science Group Holdings Ltd. - Product / Service
• Exhibit 163: LGC Science Group Holdings Ltd. - Key offerings
• 12.12 Maravai LifeSciences Holdings Inc.
• Exhibit 164: Maravai LifeSciences Holdings Inc. - Overview
• Exhibit 165: Maravai LifeSciences Holdings Inc. - Business segments
• Exhibit 166: Maravai LifeSciences Holdings Inc. - Key offerings
• Exhibit 167: Maravai LifeSciences Holdings Inc. - Segment focus
• 12.13 Merck KGaA
• Exhibit 168: Merck KGaA - Overview
• Exhibit 169: Merck KGaA - Business segments
• Exhibit 170: Merck KGaA - Key news
• Exhibit 171: Merck KGaA - Key offerings
• Exhibit 172: Merck KGaA - Segment focus
• 12.14 Mettler Toledo International Inc.
• Exhibit 173: Mettler Toledo International Inc. - Overview
• Exhibit 174: Mettler Toledo International Inc. - Business segments
• Exhibit 175: Mettler Toledo International Inc. - Key offerings
• Exhibit 176: Mettler Toledo International Inc. - Segment focus
• 12.15 Sarepta Therapeutics Inc
• Exhibit 177: Sarepta Therapeutics Inc - Overview
• Exhibit 178: Sarepta Therapeutics Inc - Product / Service
• Exhibit 179: Sarepta Therapeutics Inc - Key offerings
• 12.16 Synbio Technologies
• Exhibit 180: Synbio Technologies - Overview
• Exhibit 181: Synbio Technologies - Product / Service
• Exhibit 182: Synbio Technologies - Key offerings
• 12.17 Thermo Fisher Scientific Inc.
• Exhibit 183: Thermo Fisher Scientific Inc. - Overview
• Exhibit 184: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 185: Thermo Fisher Scientific Inc. - Key news
• Exhibit 186: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 187: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 188: Inclusions checklist
• Exhibit 189: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 190: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 191: Research methodology
• Exhibit 192: Validation techniques employed for market sizing
• Exhibit 193: Information sources
• 13.5 List of abbreviations
• Exhibit 194: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global oligonucleotide synthesis market 2017 - 2021 ($ billion)
• Exhibits19: Historic Market Size - Applications Segment 2017 - 2021 ($ billion)
• Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Application - Market share 2022-2027 (%)
• Exhibits31: Data Table on Application - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Application
• Exhibits33: Data Table on Comparison by Application
• Exhibits34: Chart on PCR primers - Market size and forecast 2022-2027 ($ billion)
• Exhibits35: Data Table on PCR primers - Market size and forecast 2022-2027 ($ billion)
• Exhibits36: Chart on PCR primers - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on PCR primers - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Fluorescence in situ hybridization - Market size and forecast 2022-2027 ($ billion)
• Exhibits39: Data Table on Fluorescence in situ hybridization - Market size and forecast 2022-2027 ($ billion)
• Exhibits40: Chart on Fluorescence in situ hybridization - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Fluorescence in situ hybridization - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on PCR assays and panels - Market size and forecast 2022-2027 ($ billion)
• Exhibits43: Data Table on PCR assays and panels - Market size and forecast 2022-2027 ($ billion)
• Exhibits44: Chart on PCR assays and panels - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on PCR assays and panels - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on DNA microarrays - Market size and forecast 2022-2027 ($ billion)
• Exhibits47: Data Table on DNA microarrays - Market size and forecast 2022-2027 ($ billion)
• Exhibits48: Chart on DNA microarrays - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on DNA microarrays - Year-over-year growth 2022-2027 (%)
• Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits54: Market opportunity by Application ($ billion)
• Exhibits55: Data Table on Market opportunity by Application ($ billion)
• Exhibits56: Chart on End-user - Market share 2022-2027 (%)
• Exhibits57: Data Table on End-user - Market share 2022-2027 (%)
• Exhibits58: Chart on Comparison by End-user
• Exhibits59: Data Table on Comparison by End-user
• Exhibits60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ billion)
• Exhibits61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ billion)
• Exhibits62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
• Exhibits64: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
• Exhibits65: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
• Exhibits66: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
• Exhibits67: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)
• Exhibits68: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
• Exhibits69: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
• Exhibits70: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
• Exhibits71: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
• Exhibits72: Chart on Hospitals - Market size and forecast 2022-2027 ($ billion)
• Exhibits73: Data Table on Hospitals - Market size and forecast 2022-2027 ($ billion)
• Exhibits74: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibits75: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibits76: Market opportunity by End-user ($ billion)
• Exhibits77: Data Table on Market opportunity by End-user ($ billion)
• Exhibits78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits79: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits81: Chart on Geographic comparison
• Exhibits82: Data Table on Geographic comparison
• Exhibits83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits85: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits89: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits93: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits101: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits109: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits111: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibits112: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibits113: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits114: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits115: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibits116: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibits117: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits118: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits119: Market opportunity By Geographical Landscape ($ billion)
• Exhibits120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits121: Impact of drivers and challenges in 2022 and 2027
• Exhibits122: Overview on Criticality of inputs and Factors of differentiation
• Exhibits123: Overview on factors of disruption
• Exhibits124: Impact of key risks on business
• Exhibits125: Vendors covered
• Exhibits126: Matrix on vendor position and classification
• Exhibits127: Agilent Technologies Inc. - Overview
• Exhibits128: Agilent Technologies Inc. - Business segments
• Exhibits129: Agilent Technologies Inc. - Key offerings
• Exhibits130: Agilent Technologies Inc. - Segment focus
• Exhibits131: Alnylam Pharmaceuticals Inc. - Overview
• Exhibits132: Alnylam Pharmaceuticals Inc. - Product / Service
• Exhibits133: Alnylam Pharmaceuticals Inc. - Key news
• Exhibits134: Alnylam Pharmaceuticals Inc. - Key offerings
• Exhibits135: Biogen Inc. - Overview
• Exhibits136: Biogen Inc. - Product / Service
• Exhibits137: Biogen Inc. - Key offerings
• Exhibits138: Biotage AB - Overview
• Exhibits139: Biotage AB - Product / Service
• Exhibits140: Biotage AB - Key news
• Exhibits141: Biotage AB - Key offerings
• Exhibits142: Danaher Corp. - Overview
• Exhibits143: Danaher Corp. - Business segments
• Exhibits144: Danaher Corp. - Key news
• Exhibits145: Danaher Corp. - Key offerings
• Exhibits146: Danaher Corp. - Segment focus
• Exhibits147: Eurofins Scientific SE - Overview
• Exhibits148: Eurofins Scientific SE - Business segments
• Exhibits149: Eurofins Scientific SE - Key news
• Exhibits150: Eurofins Scientific SE - Key offerings
• Exhibits151: Eurofins Scientific SE - Segment focus
• Exhibits152: Ionis Pharmaceuticals Inc. - Overview
• Exhibits153: Ionis Pharmaceuticals Inc. - Business segments
• Exhibits154: Ionis Pharmaceuticals Inc. - Key news
• Exhibits155: Ionis Pharmaceuticals Inc. - Key offerings
• Exhibits156: Ionis Pharmaceuticals Inc. - Segment focus
• Exhibits157: Kaneka Corp. - Overview
• Exhibits158: Kaneka Corp. - Business segments
• Exhibits159: Kaneka Corp. - Key offerings
• Exhibits160: Kaneka Corp. - Segment focus
• Exhibits161: LGC Science Group Holdings Ltd. - Overview
• Exhibits162: LGC Science Group Holdings Ltd. - Product / Service
• Exhibits163: LGC Science Group Holdings Ltd. - Key offerings
• Exhibits164: Maravai LifeSciences Holdings Inc. - Overview
• Exhibits165: Maravai LifeSciences Holdings Inc. - Business segments
• Exhibits166: Maravai LifeSciences Holdings Inc. - Key offerings
• Exhibits167: Maravai LifeSciences Holdings Inc. - Segment focus
• Exhibits168: Merck KGaA - Overview
• Exhibits169: Merck KGaA - Business segments
• Exhibits170: Merck KGaA - Key news
• Exhibits171: Merck KGaA - Key offerings
• Exhibits172: Merck KGaA - Segment focus
• Exhibits173: Mettler Toledo International Inc. - Overview
• Exhibits174: Mettler Toledo International Inc. - Business segments
• Exhibits175: Mettler Toledo International Inc. - Key offerings
• Exhibits176: Mettler Toledo International Inc. - Segment focus
• Exhibits177: Sarepta Therapeutics Inc - Overview
• Exhibits178: Sarepta Therapeutics Inc - Product / Service
• Exhibits179: Sarepta Therapeutics Inc - Key offerings
• Exhibits180: Synbio Technologies - Overview
• Exhibits181: Synbio Technologies - Product / Service
• Exhibits182: Synbio Technologies - Key offerings
• Exhibits183: Thermo Fisher Scientific Inc. - Overview
• Exhibits184: Thermo Fisher Scientific Inc. - Business segments
• Exhibits185: Thermo Fisher Scientific Inc. - Key news
• Exhibits186: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits187: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits188: Inclusions checklist
• Exhibits189: Exclusions checklist
• Exhibits190: Currency conversion rates for US$
• Exhibits191: Research methodology
• Exhibits192: Validation techniques employed for market sizing
• Exhibits193: Information sources
• Exhibits194: List of abbreviations